New Hampshire Reaches $40.5 Million Opioid Settlement with Johnson & Johnson
- September 02, 2022
Johnson & Johnson and its Janssen Pharmaceutical unit agreed to pay $40.5 million to New Hampshire to resolve claims against the drug maker for its alleged role in fueling the state’s opioid epidemic.
ARTICLE TAGS
You must be logged in to access this content.